

Ventricular Assistance Devices Market Scope:
Request Sample Report
The Ventricular Assistance Devices (VAD) market is experiencing robust growth, driven by increasing heart failure prevalence and technological advancements. The global market size is projected to reach approximately $2.5 billion by 2028, reflecting significant investment in innovative solutions, patient management, and expanding applications in both chronic and acute heart conditions.
Sample Report
◍ Abiomed
◍ Berlin Heart
◍ Cardiac Assist
◍ HeartWare
◍ Jarvik Heart
◍ Reliant Heart
◍ Abbott
◍ Sun Medical
◍ Syncardia System
◍ Thoratec
The Ventricular Assistance Devices market involves key players like Abiomed, Berlin Heart, and Abbott, among others. These companies drive innovation and market growth through advanced technologies and diverse product offerings. Revenue contributions include:
- Abbott: $10 billion (2022)
- Abiomed: $1.09 billion (2022)
- Thoratec: $1.06 billion (2015)
Their collaboration enhances treatment options for heart failure patients.
Request Sample Report
Hospital
Clinic
Request Sample Report
Right Ventricular Assist Device
Left Ventricular Assist Device
Bi-ventricular Assist Device
Request Sample Report
$ X Billion USD